Treatment of refractory complex partial seizures: role of vigabatrin.
about
Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptorsEffects of GABA-transaminase inhibitor Vigabatrin on thermoregulation in ratsClinical trial of vigabatrin as adjunctive therapy in children with refractory epilepsy.The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile sDesign and mechanism of tetrahydrothiophene-based γ-aminobutyric acid aminotransferase inactivators.Mechanism of Inactivation of GABA Aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic Acid.Treatment options for refractory and difficult to treat seizures: focus on vigabatrinVigabatrin therapy for refractory complex partial seizures: review of major European trials.Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States.Understanding and interpreting vision safety issues with vigabatrin therapy.Balancing clinical benefits of vigabatrin with its associated risk of vision loss.Vigabatrin-associated retinal damage: potential biochemical mechanisms.Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction.Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations.
P2860
Q28483144-D50298B6-456D-4186-B8E4-22A25B57D700Q28569234-2EDE3556-4D64-42A1-8B61-1421BBE9AAD1Q33628299-A576CBE0-ABD3-4CAC-93EA-9CF48CEEB464Q34240602-455EFA6E-E1B7-41D6-B24D-7741D9880B31Q35329906-710F8309-5E81-42DE-88D4-D234CE4B04F1Q36074460-474E1997-8D43-4E95-831B-024C54D1E9D5Q37937441-5C7B1125-FC7C-45EA-8DAA-7433C61FF808Q37953576-F29FF73F-5EDA-4298-848A-E3A6B3EC0DFFQ37953578-E4B02E32-1754-443A-8722-63DB941D9F5AQ37953582-ABDB5E5A-5E18-4B8A-9F21-0A1954769A4DQ37953583-BD29A6E0-C8FA-4D24-A700-B4B90FE80A00Q38013194-754B9BEB-D8AA-4AB3-B9A1-A8D6AACC41EEQ47832021-6C2C1123-3A4C-4092-8E0F-CB2CD3CF3C84Q48552376-0236DA0B-563D-4682-AB99-500C642CE079
P2860
Treatment of refractory complex partial seizures: role of vigabatrin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of refractory complex partial seizures: role of vigabatrin.
@en
Treatment of refractory complex partial seizures: role of vigabatrin.
@nl
type
label
Treatment of refractory complex partial seizures: role of vigabatrin.
@en
Treatment of refractory complex partial seizures: role of vigabatrin.
@nl
prefLabel
Treatment of refractory complex partial seizures: role of vigabatrin.
@en
Treatment of refractory complex partial seizures: role of vigabatrin.
@nl
P2093
P2860
P356
P1476
Treatment of refractory complex partial seizures: role of vigabatrin.
@en
P2093
Elizabeth J Waterhouse
Kimberly N Mims
Soundarya N Gowda
P2860
P304
P356
10.2147/NDT.S5236
P407
P577
2009-10-12T00:00:00Z